Speaker(s): 

Divvy Upadhyay, MD, MPH - has nothing to disclose

Michael Evans, RPh, MBA, FASHP, Staff, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Discuss the complex policies that have historically influenced drug pricing.
• Contemporary drug pricing policy issues in the context of consolidation and market power.
• Appreciate the role pharmacy plays in value-based care organizations such as Risant/ Geisinger

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Scott Friedenberg, MD, Nicole Woll, PhD, MEd, Rob Cooney, MD, MSMedEd, Karen Tillotson, PA-C, Rebecca Stoudt, DNP, PhD, CRNA, Daniel Longyhore, PharmD, Kristi Shirk, BA, and Annie Seif, BS have no identified disclosures. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None